Efficacy and Safety of Rovalpituzumab Tesirine Compared With Topotecan as Second-Line Therapy in DLL3-High SCLC: Results From the Phase 3 TAHOE Study - Concepedia

Concepedia

Publication | Open Access

Efficacy and Safety of Rovalpituzumab Tesirine Compared With Topotecan as Second-Line Therapy in DLL3-High SCLC: Results From the Phase 3 TAHOE Study

DOI Full Paper Access

239

Citations

18

References

2021

Year

Fiona Blackhall, Kevin Jao, Laurent Greillier, Byoung Chul Cho, Konstantin Penkov, Noemı́ Reguart, Margarita Majem, Kristiaan Nackaerts, Konstantinos Syrigos, Karin Holmskov Hansen,

Journal of Thoracic Oncology

References

	Year	Citations

Page 1